By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Jazz Pharmaceuticals 

Corporate Headquarters
Fourth Floor, Connaught House

One Burlington Road
Dublin    4  Ireland
Phone: 353-1-634-7800 Fax: 353-1-634-7850


Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a specialty biopharmaceutical company of over 875 employees focused on diverse portfolio of products and/or product candidates in the areas of sleep, hematology/oncology, pain and psychiatry.

Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has U.S. offices in Palo Alto, CA and Philadelphia, PA, and has offices in various other locations in Europe. The company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what they do to accomplish results by driving to achieve Jazz’s mission: to improve patients’ lives by identifying, developing and commercializing important specialty pharmaceutical products to address unmet patient needs, and operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence.

U.S. addresses:
3180 Porter Drive
Palo Alto, CA 94304

1818 Market Street
Philadelphia, PA 19103

Key Statistics

Ownership: Public

Web Site: Jazz Pharmaceuticals
Symbol: JAZZ


Company News
Jazz Pharmaceuticals (JAZZ) Announces Participation In Two Investor Conferences 5/18/2015 10:52:02 AM
Jazz Pharmaceuticals (JAZZ) And Concert Pharmaceuticals Provide JZP-386 Program Update 5/8/2015 10:19:39 AM
Jazz Pharmaceuticals (JAZZ) Announces First Quarter 2015 Financial Results 5/8/2015 7:30:56 AM
Jazz Pharmaceuticals (JAZZ) To Report 2015 First Quarter Financial Results On May 7, 2015 4/27/2015 9:59:35 AM
EUSA Pharma Successfully Launches As An Independent Profitable Pharmaceutical Business With Global Reach And A Portfolio Of Specialty Products Acquired From Jazz Pharmaceuticals (JAZZ) 3/23/2015 8:25:54 AM
Jazz Pharmaceuticals (JAZZ) Announces Full Year And Fourth Quarter 2014 Financial Results 2/25/2015 9:20:40 AM
Jazz Pharmaceuticals (JAZZ) Announces Participation In Two Investor Conferences In March 2/24/2015 7:58:29 AM
Jazz Pharmaceuticals (JAZZ) To Present Data On Defibrotide, An Investigational Treatment, In Patients With Hepatic Veno-Occlusive Disease (VOD) At BMT Tandem Meetings 2/12/2015 7:36:13 AM
Jazz Pharmaceuticals (JAZZ) To Report 2014 Fourth Quarter And Full Year Financial Results On February 24, 2015 2/11/2015 10:35:17 AM
Jazz Pharmaceuticals (JAZZ) Signs Lease for Big Space in Palo Alto 1/13/2015 3:32:36 PM